Company Quick10K Filing
Johnson & Johnson
10-Q 2020-06-28 Filed 2020-07-24
10-Q 2020-03-29 Filed 2020-04-29
10-K 2019-12-29 Filed 2020-02-18
10-Q 2019-09-29 Filed 2019-10-28
10-Q 2019-06-30 Filed 2019-07-29
10-Q 2019-03-31 Filed 2019-05-01
10-K 2018-12-30 Filed 2019-02-20
10-Q 2018-09-30 Filed 2018-10-31
10-Q 2018-07-01 Filed 2018-08-02
10-Q 2018-04-01 Filed 2018-05-01
10-K 2017-12-31 Filed 2018-02-21
10-Q 2017-10-01 Filed 2017-11-02
10-Q 2017-07-02 Filed 2017-08-03
10-Q 2017-04-02 Filed 2017-05-08
10-K 2017-01-01 Filed 2017-02-27
10-Q 2016-10-02 Filed 2016-11-04
10-Q 2016-07-03 Filed 2016-08-04
10-Q 2016-04-03 Filed 2016-05-10
10-K 2016-01-03 Filed 2016-02-24
10-Q 2015-09-27 Filed 2015-10-30
10-Q 2015-06-28 Filed 2015-07-31
10-Q 2015-03-29 Filed 2015-05-01
10-K 2014-12-28 Filed 2015-02-24
10-Q 2014-09-28 Filed 2014-10-30
10-Q 2014-06-29 Filed 2014-08-01
10-Q 2014-03-30 Filed 2014-05-02
10-K 2013-12-29 Filed 2014-02-21
10-Q 2013-09-29 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-30 Filed 2013-02-22
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-07-01 Filed 2012-08-02
10-Q 2012-04-01 Filed 2012-05-07
10-K 2012-01-01 Filed 2012-02-23
10-Q 2011-10-02 Filed 2011-11-08
10-Q 2011-07-03 Filed 2011-08-09
10-Q 2011-04-03 Filed 2011-05-10
10-K 2011-01-02 Filed 2011-02-25
10-Q 2010-10-03 Filed 2010-11-10
10-Q 2010-07-04 Filed 2010-08-11
10-Q 2010-04-04 Filed 2010-05-10
10-K 2010-01-03 Filed 2010-03-01
8-K 2020-08-20 Other Events, Exhibits
8-K 2020-08-12 Other Events, Exhibits
8-K 2020-07-16 Earnings, Exhibits
8-K 2020-06-09
8-K 2020-04-23
8-K 2020-04-14
8-K 2020-02-12
8-K 2020-01-22
8-K 2019-12-05
8-K 2019-10-23
8-K 2019-10-15
8-K 2019-10-07
8-K 2019-08-26
8-K 2019-07-16
8-K 2019-04-25
8-K 2019-04-16
8-K 2019-04-01
8-K 2019-04-01
8-K 2019-03-21
8-K 2019-01-22
8-K 2019-01-17
8-K 2018-12-17
8-K 2018-10-23
8-K 2018-10-16
8-K 2018-10-02
8-K 2018-07-17
8-K 2018-06-22
8-K 2018-05-14
8-K 2018-04-26
8-K 2018-04-17
8-K 2018-03-20
8-K 2018-01-23

Johnson & Johnson Financials

JNJ Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Johnson & Johnson (JNJ) 345,690 66% 16.4 9% 155,521 97,311 81,706 54,323 14,151 21,578 354,665
Merck (MRK) 214,488 70% 18.9 9% 83,331 56,493 34,973 24,530 7,492 12,141 229,294
Pfizer (PFE) 207,742 81% 12.0 10% 170,446 105,051 39,062 31,451 16,629 20,353 243,371
GlaxoSmithKline (GSK) 200,316 0% 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 0% 145,563 66,871 0 0 0 0 193,929
Abbott (ABT) 150,169 59% 16.4 5% 67,887 36,586 31,904 18,673 3,687 10,019 164,168
AbbVie (ABBV) 109,786 77% 21.1 5% 59,441 67,667 32,867 25,412 3,255 6,259 132,264
Eli Lilly (LLY) 105,897 78% 12.7 21% 37,893 34,431 22,644 17,612 7,948 9,419 119,560
Beigene (BGNE) 100,124 74% -123.1 -44% 1,881 587 430 318 -827 -807 99,328
Bristol Myers Squibb (BMY) 82,160 70% 10.6 10% 57,433 39,679 24,173 16,837 5,680 7,151 76,061
Celgene (CELG) 72,111 96% 10.4 14% 41,363 29,276 16,982 16,354 5,880 7,734 80,796
Zoetis (ZTS) 60,799 51% 29.1 13% 11,272 8,594 6,150 3,124 1,461 2,252 65,484
Allergan (AGN) 54,957 63% -241.2 -5% 122,925 38,486 15,818 9,949 -5,872 -316 76,270
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
GW Pharmaceuticals (GWPH) 45,954 89% -870.1 -8% 848 128 205 182 -64 -52 45,400
Vertex Pharmaceuticals (VRTX) 43,431 87% 46.7 29% 7,515 2,261 3,620 3,135 2,144 857 40,027
Regeneron Pharmaceuticals (REGN) 32,266 0% 12.2 15% 13,939 3,435 7,622 0 2,144 2,539 30,869
Alexion Pharmaceuticals (ALXN) 23,581 92% 12.8 10% 14,815 4,448 4,736 4,359 1,470 1,874 23,912
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458

Balance Sheet ($MM)2010-01-032010-04-042010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash15,81013,74312,71314,33819,35522,35614,97415,61732,26130,26714,04215,48621,08914,85517,30717,20429,20619,72214,23613,81833,08911,98810,63913,63913,73213,86118,64018,20518,97220,90912,59815,72117,82414,63917,56916,05618,10714,73414,37617,944
Accounts Receivable9,64610,0189,62910,2909,77410,86110,98210,55210,58110,98210,99211,17511,30911,51511,61412,02711,71312,11612,25711,61510,98511,53311,96811,36610,73411,40612,06211,79811,69912,30013,28313,15513,49014,16614,11114,04814,09814,11514,65314,801
Inventory5,1805,3085,0715,4095,3786,2006,4136,4286,2856,8007,6977,8097,4957,6917,8228,1247,8788,0098,1558,4198,1848,0858,2988,2068,0538,1708,5238,4888,1448,8789,6999,5218,7659,0148,8108,6788,5999,0869,2639,173
PP&E14,75928,96328,49929,92730,42631,80532,43531,73631,82932,55033,29734,08234,65434,69535,40136,43237,13336,24836,94736,44836,68535,40336,11236,39736,64837,43037,77938,37337,77338,69640,07540,92841,46641,99641,29341,52041,85142,26242,90542,625
Assets94,68293,44192,30098,247102,908108,150112,114111,821113,644116,194115,750118,951121,347121,536124,325126,933132,683133,330135,200132,097131,119128,590132,036133,266133,411136,231139,814140,369141,208144,918152,807155,658157,303156,625155,365155,703152,954150,027155,117155,521
Accounts Payable5,5415,1264,8715,4775,6235,7015,6895,7305,7255,0855,1455,3445,8315,3725,6876,0556,2666,1136,1936,6037,6336,7196,1405,9286,6685,9656,0615,9716,9186,0826,1356,3907,3106,4436,5167,0007,5376,9236,9127,491
Long-Term Debt8,2238,0597,9379,1829,1699,25513,68013,03112,96913,01011,52511,42811,48911,3639,6439,74813,32813,34313,30313,15215,12214,93814,08514,07312,85720,23324,53523,54622,44227,01527,36326,67532,17529,83729,40529,48030,28427,66027,69926,919
Liabilities44,09440,52739,44940,95646,32948,28749,98250,29456,56454,82855,31655,19056,52154,68154,66057,12958,63056,74857,15255,50661,36760,71260,90561,71262,26163,58467,34167,60070,79074,57780,88581,67997,14393,37092,47691,07793,20291,07294,33297,311
Stockholders' Equity
Income Statement ($MM)2010-01-032010-04-042010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Revenue15,63115,33014,98215,64416,17317,78816,00516,25516,13916,47517,05217,55817,50517,87717,57518,35518,11519,49518,46718,25417,37417,78717,10217,81117,48218,48217,82018,10617,76618,83919,65020,19520,00920,83020,34820,39420,02120,56220,729
Cost of Revenue4,5284,6304,5945,0404,7785,3565,0725,3384,9155,1435,5976,0035,5545,4895,3445,9555,4556,0395,3995,8535,2825,3575,2245,6735,3295,3365,4865,5345,3865,8236,9027,2436,6146,9276,5896,9616,6156,9406,867
Gross Profit11,10310,70010,38810,60411,39512,43210,93310,91711,22411,33211,45511,55511,95112,38812,23112,40012,66013,45613,06812,40112,09212,43011,87812,13812,15313,14612,33412,57212,38013,01612,74812,95213,39513,90313,75913,43313,40613,62213,862
R&D1,5571,6481,6571,9821,7381,9631,7732,1551,6451,7661,9232,3311,7841,9462,0422,4111,8312,0052,0232,6351,8992,1292,1542,8642,0132,2642,1782,6402,0602,2852,5743,6352,4042,6392,5082,8582,6662,599
SG&A4,7794,7564,7095,1805,0565,5625,2405,4585,0154,9655,2285,6615,2235,3765,3145,9175,1835,4815,4685,8224,8475,3845,0815,8914,6885,1764,7725,3094,7375,2625,3966,0255,2635,7435,5435,2195,5465,374
Tax1,7547718022861,0348789091001,135627966533764960685-7696971,3002,0611821,2551,2257645431,0029071,0095101,1539211,02613,2731,1141,0194896731,434-106
Net Income4,5263,4493,4171,9423,4762,8353,2022183,9101,4082,9682,5673,4973,8332,9823,5194,7274,3264,7492,5214,3204,5163,3583,2154,2923,9974,2723,8144,4223,8273,764-10,7134,3673,9543,9343,0423,7495,6071,753
Cash Flow ($MM)2010-01-032010-04-042010-07-042010-10-032011-01-022011-04-032011-07-032011-10-022012-01-012012-04-012012-07-012012-09-302012-12-302013-03-312013-06-302013-09-292013-12-292014-03-302014-06-292014-09-282014-12-282015-03-292015-06-282015-09-272016-01-032016-04-032016-07-032016-10-022017-01-012017-04-022017-07-022017-10-012017-12-312018-04-012018-07-012018-09-302018-12-302019-03-312019-06-302019-09-29
Cash Operating3,6903,8375,0343,8242,3163,9094,6223,4512,7954,7284,4973,3762,2775,0515,9474,1393,9235,5294,6544,3652,8725,2006,1255,0821,7634,9905,3616,6532,9135,7726,2666,1053,6066,0796,2723,5435,9487,527
Cash Investing-1,882-2,693-1,875-1,4041,440-10,700-1,5906,2384,056-17,46111,398-2,503-1,403-569-1,553-1,578-2,026-8,092735-2,922-1,789-3,554-1,001-1,391-1,5371,322-2,372-2,174-936-12,247-1,180-505-925-201-4,269-1,417-1,788-1,645
Cash Financing-3,822-2,065-1,6992,606-825-639-2,232-756-1,183-3,403-14,505-1,471-777-1,977-4,5191,182-3,057-2,868-5,716-619-3,227-2,503-1,825-3,291-178-1,464-3,445-3,464-150-1,917-2,069-3,537-5,970-2,674-3,477-5,516-4,534-3,893